1. Home
  2. HRMY vs RNST Comparison

HRMY vs RNST Comparison

Compare HRMY & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • RNST
  • Stock Information
  • Founded
  • HRMY 2017
  • RNST 1904
  • Country
  • HRMY United States
  • RNST United States
  • Employees
  • HRMY N/A
  • RNST N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • RNST Major Banks
  • Sector
  • HRMY Health Care
  • RNST Finance
  • Exchange
  • HRMY Nasdaq
  • RNST Nasdaq
  • Market Cap
  • HRMY 1.9B
  • RNST 1.8B
  • IPO Year
  • HRMY 2020
  • RNST N/A
  • Fundamental
  • Price
  • HRMY $34.83
  • RNST $35.38
  • Analyst Decision
  • HRMY Buy
  • RNST Buy
  • Analyst Count
  • HRMY 10
  • RNST 5
  • Target Price
  • HRMY $49.80
  • RNST $40.75
  • AVG Volume (30 Days)
  • HRMY 539.5K
  • RNST 556.1K
  • Earning Date
  • HRMY 02-20-2025
  • RNST 01-21-2025
  • Dividend Yield
  • HRMY N/A
  • RNST 2.47%
  • EPS Growth
  • HRMY N/A
  • RNST 6.89
  • EPS
  • HRMY 2.11
  • RNST 3.09
  • Revenue
  • HRMY $681,879,000.00
  • RNST $685,874,000.00
  • Revenue This Year
  • HRMY $24.83
  • RNST N/A
  • Revenue Next Year
  • HRMY $18.66
  • RNST $36.82
  • P/E Ratio
  • HRMY $16.53
  • RNST $11.57
  • Revenue Growth
  • HRMY 25.83
  • RNST 8.24
  • 52 Week Low
  • HRMY $28.14
  • RNST $27.98
  • 52 Week High
  • HRMY $41.61
  • RNST $39.47
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 55.30
  • RNST 43.52
  • Support Level
  • HRMY $33.36
  • RNST $34.03
  • Resistance Level
  • HRMY $34.96
  • RNST $36.39
  • Average True Range (ATR)
  • HRMY 1.19
  • RNST 1.03
  • MACD
  • HRMY 0.16
  • RNST -0.11
  • Stochastic Oscillator
  • HRMY 81.62
  • RNST 36.59

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation operates in the southern United States.

Share on Social Networks: